LD-2 disclosure · 1st Quarter - Report
MEDCO HEALTH SOLUTIONS INC
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, DC, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Health Information Technology, HIPAA Privacy and Security Rules, Biogenerics, Comparative Effectivesness, Chronic Care Management HR 1 - American Recovery and Reinvestment Act of 2009; Title VIII Departments of Labor, Health and Human Services, and Education, and Related Agencies, Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act HR 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections. HR 1548 - Pathway for Biosimilars Act; all aspects
LobbyistsBILL HEAD · PETER BEGANS · ALLYSON BLANDFORD · HEATHER STEWART · KIMBERLY LINTHICUM
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Federal Trade Commission (FTC) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Medicare Part D, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment, Importation of Prescription Drugs HR 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all aspects HR 1204 - Community Pharmacy Fairness Act of 2009; all sections HR 1765 - To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program S. 525 - Pharmaceutical Market Access and Drug Safety Act of 2009; all aspects
LobbyistsBILL HEAD · PETER BEGANS · ALLYSON BLANDFORD · HEATHER STEWART · KIMBERLY LINTHICUM
